Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols

被引:18
作者
Fetoni, Anna Rita [1 ,2 ]
Paciello, Fabiola [2 ,3 ]
Troiani, Diana [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Head & Neck Surg, Largo F Vito 1, I-00168 Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Dept Neurosci, Rome, Italy
关键词
cancer; cochlea; therapeutic adjuvant; Nrf-2; chemoresistance; NF-KAPPA-B; INDUCED HEARING-LOSS; AUDITORY HAIR-CELLS; INDUCED OTOTOXICITY; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; GENETIC-VARIANTS; CANCER-PATIENTS; INDUCED NEPHROTOXICITY; SUPEROXIDE-DISMUTASE;
D O I
10.1089/ars.2021.0183
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Cisplatin is an important component of treatment regimens for different cancers. Notwithstanding that therapeutic success often results from partial efficacy or stabilizing the disease, chemotherapy failure is driven by resistance to drug treatment and occurrence of side effects, such as progressive irreversible ototoxicity. Cisplatin's side effects, including ototoxicity, are often dose limiting.Recent Advances: Cisplatin ototoxicity results from several mechanisms, including redox imbalance caused by reactive oxygen species production and lipid peroxidation, activation of inflammation, and p53 and its downstream pathways that culminate in apoptosis. Considerable efforts in research have targeted development of molecular interventions that can be concurrently administered with cisplatin or other chemotherapies to reduce side effect toxicities while preserving or enhancing the antineoplastic effects. Evidence from studies has indicated some polyphenols, such as curcumin, can help to regulate redox signaling and inflammatory effects. Furthermore, polyphenols can exert opposing effects in different types of tissues, that is, normal cells undergoing stressful conditions versus cancer cells.Critical Issues: This review article summarizes evidence of curcumin antioxidant effect against cisplatin-induced ototoxicity that is converted to a pro-oxidant activity in cisplatin-treated cancer cells, thus providing an ideal chemosensitivity combined with otoprotection. Polyphenols can modulate the adaptive responses to stress in the cisplatin-exposed cochlea. These adaptive effects can result from the interaction/cross talk between the cell's defenses, inflammatory molecules, and the key signaling molecules of signal transducers and activators of transcription 3 (STAT-3), nuclear factor kappa-B (NF-kappa B), p53, and nuclear factor erythroid 2-related factor 2 (Nrf-2).Future Directions: We provide molecular evidence for alternative strategies for chemotherapy with cisplatin addressing the otoprotection and chemosensitization properties of polyphenols.
引用
收藏
页码:1229 / 1245
页数:17
相关论文
共 200 条
  • [1] Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling
    Aggarwal, S
    Takada, Y
    Singh, S
    Myers, JN
    Aggarwal, BB
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) : 679 - 692
  • [2] Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea
    Alam, SA
    Ikeda, K
    Oshima, T
    Suzuki, M
    Kawase, T
    Kikuchi, T
    Takasaka, T
    [J]. HEARING RESEARCH, 2000, 141 (1-2) : 28 - 38
  • [3] Functional Hair Cell Mechanotransducer Channels Are Required for Aminoglycoside Ototoxicity
    Alharazneh, Abdelrahman
    Luk, Lauren
    Huth, Markus
    Monfared, Ashkan
    Steyger, Peter S.
    Cheng, Alan G.
    Ricci, Anthony J.
    [J]. PLOS ONE, 2011, 6 (07):
  • [4] Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
    Alimbetov, Dauren
    Askarova, Sholpan
    Umbayev, Bauyrzhan
    Davis, Terence
    Kipling, David
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06)
  • [5] NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)
    Almeida, Luciana O.
    Abrahao, Aline C.
    Rosselli-Murai, Luciana K.
    Giudice, Fernanda S.
    Zagni, Chiara
    Leopoldino, Andreia M.
    Squarize, Cristiane H.
    Castilho, Rogerio M.
    [J]. FEBS OPEN BIO, 2014, 4 : 96 - 104
  • [6] ABC Transporter-Mediated Multidrug-Resistant Cancer
    Amawi, Haneen
    Sim, Hong-May
    Tiwari, Amit K.
    Ambudkar, Suresh V.
    Shukla, Suneet
    [J]. DRUG TRANSPORTERS IN DRUG DISPOSITION, EFFECTS AND TOXICITY, 2019, 1141 : 549 - 580
  • [7] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Armstrong, DK
    Bundy, B
    Wenzel, L
    Huang, HQ
    Baergen, R
    Lele, S
    Copeland, LJ
    Walker, JL
    Burger, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) : 34 - 43
  • [8] The multi-factorial nature of clinical multidrug resistance in cancer
    Assaraf, Yehuda G.
    Brozovic, Anamaria
    Goncalves, Ana Cristina
    Jurkovicova, Dana
    Line, Aija
    Machuqueiro, Miguel
    Saponara, Simona
    Sarmento-Ribeiro, Ana Bela
    Xavier, Cristina P. R.
    Vasconcelos, M. Helena
    [J]. DRUG RESISTANCE UPDATES, 2019, 46
  • [9] RETRACTED: Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture (Retracted Article)
    Aydin, Yucel
    Chedid, Milad
    Chava, Srinivas
    Williams, Donkita Danielle
    Liu, Shuanghu
    Hagedorn, Curt H.
    Sumitran-Holgersson, Suchitra
    Reiss, Krzysztof
    Moroz, Krzysztof
    Lu, Hua
    Balart, Luis A.
    Dash, Srikanta
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [10] Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
    Bai, Xupeng
    Chen, Yibei
    Hou, Xiangyu
    Huang, Min
    Jin, Jing
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 (04) : 541 - 567